DIA 2017
June 18-22, 2017
Chicago, IL
Menu Back to Committee
DIA 2017

DIA 2017 is located at:

McCormick Place
Gate 4
2301 South Martin Luther King Jr. Drive
Chicago, IL
Go

Program Committee

  • Teresa Ancukiewicz, MA
    Teresa Ancukiewicz, MA • Associate Director
    Boston Scientific Corporation, United States
  • Kimberly Belsky, MS
    Kimberly Belsky, MS • Executive Director Reg Policy & Intell, AdPromo, RegOps, Regulatory Affairs
    Mallinckrodt Pharmaceuticals, United States
  • Larry A. Blankstein, PhD
    Larry A. Blankstein, PhD • Head of Clinical Operations
    Synlogic, United States
  • Daniel Bollag, PhD
    Daniel Bollag, PhD • Chief Strategy Officer
    Ocular Therapeutics, United States
  • Linda Bowen, MSc, RAC
    Linda Bowen, MSc, RAC • Executive Director and Head of the Regulatory Centers of Excellence
    Seagen Inc., United States
  • Bill Byrom, PhD
    Bill Byrom, PhD • Principal, eCOA Science
    Signant Health , United Kingdom
  • Joy A. Cavagnaro, PhD
    Joy A. Cavagnaro, PhD • President
    Access BIO, United States
  • Dannis Chang, PharmD
    Dannis Chang, PharmD • Executive Director, Head of Medical Capabilities
    Mirati Therapeutics , United States
  • Karla Childers, MS
    Karla Childers, MS • Bioethics & Strategic Projects Leader, Office of the Chief Medical Officer
    Johnson & Johnson, United States
  • Leah Christl, PhD
    Leah Christl, PhD • Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
    Amgen, United States
  • Brenda Crowe, PhD
    Brenda Crowe, PhD • Associate Vice President, Statistics
    Eli Lilly and Company, United States
  • Sara Doshi, PharmD
    Sara Doshi, PharmD • Director, Medical Information Strategy and Capabilities, GMI
    Eli Lilly and Company, United States
  • Betsy Fallen, RN
    Betsy Fallen, RN • Consultant
    BAFallen Consulting LLC, United States
  • Barbara Gladson, PhD, MS
    Barbara Gladson, PhD, MS • Director of Biopharma Initiative; Interim Chair, Health Informatics
    Rutgers School of Health Professions, United States
  • Richard Gliklich, MD
    Richard Gliklich, MD • CEO
    OM1, United States
  • Jonathan Haddad, MPH
    Jonathan Haddad, MPH • HIV Disease Area Head, Clinical Statistics
    GlaxoSmithKline, United States
  • Martin Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM • Head of International Affairs
    European Medicines Agency, Netherlands
  • Jonathan Solomon Helfgott, MS
    Jonathan Solomon Helfgott, MS • Executive Director, Global Regulatory/Clinical Affairs
    Stage 2 Innovations, United States
  • Frank Hubbard, PhD, MS
    Frank Hubbard, PhD, MS • President
    Global Regulatory Writing Solutions Inc., United States
  • Virginia Hussong
    Virginia Hussong • Chief, Data Standards Program, CBER
    FDA, United States
  • Nita Ichhpurani, PMP
    Nita Ichhpurani, PMP • Consultant To Daiichi Sankyo, Inc.
    Phase One Forward, Consultant, Canada
  • John Kamp
    John Kamp • Washington Counsel
    Coalition For Healthcare Communication (CHC), United States
  • Sean Kassim, PhD
    Sean Kassim, PhD • Director, Office of Study Integrity and Surveillance, OTS, CDER
    FDA, United States
  • Ellen Kelso
    Ellen Kelso • Head, Knowledge Strategy
    KSE Ltd., United States
  • Lisa Kim, MS
    Lisa Kim, MS • Program Director / Lecturer
    Rutgers School of Health Professions, United States
  • Lynn King, MHA
    Lynn King, MHA • Chief Operating Officer
    M3 Wake Research, United States
  • Agnes Klein, MD
    Agnes Klein, MD • Senior Medical Advisor
    Health Canada, Canada
  • Stephen Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP • Chief Medical Officer
    Halozyme Therapeutics, United States
  • Mark Kryah, PMP
    Mark Kryah, PMP • Executive Director/Program Team Leader
    Ultragenyx, United States
  • Andrea C. Masciale, JD
    Andrea C. Masciale, JD • Vice President, Regulatory Policy and Global Analytics
    Johnson & Johnson, United States
  • Ann Meeker-O'Connell, MS
    Ann Meeker-O'Connell, MS • Director, Office of Clinical Policy, Office of Clinical Policy and Programs, OC
    FDA, United States
  • Mary Murray, MBA, MS
    Mary Murray, MBA, MS • Independent
    Independent, United States
  • Bob Muzerall
    Bob Muzerall • Vice President, Sales & Sales Training
    AMPLEXOR Life Sciences, LLC, United States
  • Jane Myles, MS
    Jane Myles, MS • VP, Clinical Trial Innovation
    Curebase, United States
  • Roger Nosal, PhD
    Roger Nosal, PhD • Vice President, Head of Global CMC
    Pfizer Inc, United States
  • Christine Pierre, RN
    Christine Pierre, RN • President
    Society for Clinical Research Sites, United States
  • Sarah Pope Miksinski, PhD
    Sarah Pope Miksinski, PhD • Senior Director, Global Regulatory Affairs
    AstraZeneca, United States
  • Kim Quaintance-Lunn
    Kim Quaintance-Lunn • Vice President, US Regulatory Lead, Regulatory Affairs Americas
    Bayer, United States
  • Badri Rengarajan, MD
    Badri Rengarajan, MD • Life Sciences
    Jazz Pharmaceuticals, United States
  • Margaret Richards, PhD, MPH
    Margaret Richards, PhD, MPH • Executive Director, Solutions
    Panalgo, United States
  • Mitra Rocca, MSc
    Mitra Rocca, MSc • Associate Director, Medical Informatics, Office of Translational Science, CDER
    FDA, United States
  • Matthew D. Rotelli, PhD, MS
    Matthew D. Rotelli, PhD, MS • Associate VP, Bioethics
    Eli Lilly and Company, United States
  • Leslie Sam
    Leslie Sam • President
    Leslie Sam and Associates, United States
  • David H. Schubert
    David H. Schubert •
    DH Schubert Regulatory Solutions LLC, United States
  • Leigh Shultz, PhD, PMP
    Leigh Shultz, PhD, PMP • Executive Director, Human Health Commercial Operations
    Merck & Co., Inc., United States
  • Ashley F. Slagle, PhD, MS
    Ashley F. Slagle, PhD, MS • Principal, Scientific and Regulatory Consulting
    Aspen Consulting, LLC, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS • Assistant Professor Regulatory & Quality Sciences
    University of Southern California School of Pharmacy, United States
  • William B. Smith, MD
    William B. Smith, MD • CEO
    Alliance for Multispecialty Research, LLC (AMR), United States
  • Elizabeth Somers, MS
    Elizabeth Somers, MS • Executive Director of Infectious Disease, Global Project and Alliance Management
    Merck Sharp & Dohme LLC, United States
  • Jeffrey N. Stuart, PhD
    Jeffrey N. Stuart, PhD • Associate Vice President, Global Regulatory Affairs
    Merck Sharp & Dohme LLC , United States
  • Ling Su, PhD
    Ling Su, PhD • Research Fellow
    Shenyang Pharmaceutical University Yeehong Business School, China
  • Toshiyoshi Tominaga, PhD
    Toshiyoshi Tominaga, PhD • Project Professor
    Keio University Hospital, Japan
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh • Vice President, Pharmacovigilance
    IQVIA, United States
Load More